Opyl

At TrialKey, we understand that CROs require quick access to accurate data, insightful analytics, and robust tools to support trial optimisation from the start. That’s why we’ve designed an onboarding process that is as seamless as it is comprehensive, empowering CROs with everything they need to excel in clinical trial design. TrialKey’s onboarding program ensures that CRO teams are equipped to use our AI-powered biostatistical validation tools to their fullest, optimising trial efficiency, patient recruitment, and trial success. Book a demo: appt.link/minhthu   #clinicaltrials #trialoptimisation #crosolutions #aiinhealthcare #datadriveninsights #trialsuccess

Opyl and Biointelect Pty Ltd are hosting a webinar on ‘Enhancing Clinical Trials: From Strategy to Execution’. The discussion will cover AI-powered tools like TrialKey, trial planning, and global regulatory alignment. Speakers: Jacqui Wade – Director of Clinical Affairs & Director Services, Biointelect Pty Ltd Dr Minh-Thu C., Business Development Manager, Opyl Moderator: Bernice Averion – Head of Marketing & Communications, Opyl When: 9am 9th April 2025 AEDT Where: https://lnkd.in/gBxBfnR3 Cameras and microphones will be off for all participants but please utilise the chat for any questions Key topics: Using AI to improve trial design Aligning trials with global regulations Reducing trial risks and delays The impact of predictive analytics on trial success Combining data-driven insights with operational expertise Register now! #clinicaltrials #drugdiscovery #aiinhealthcare #biotech #medtech #pharmaceutical #biopharma #asx #webinar #CRO #contractresearchorganisation #commercialisation #regulatory

Executive Chairman of Opyl, Saurabh Jain, joined the Geeks Of The Valley podcast, a series that connects with global industry leaders to discuss emerging trends in venture capital, private equity, and innovation. This episode, ‘Revolutionizing Global Healthcare Through AI,’ dives into how AI is reshaping clinical trials and why automation is needed to improve trial success rates. It's well worth a episode here: here: https://lnkd.in/gKyHGvzF Opyl is at the forefront of AI-driven clinical trial optimisation, and TrialKey's AI is solving one of the biggest challenges in research: poor trial design. Researchers often rely on fragmented datasets due to relevant trials dispered across multiple global registries, and less than 20% of trials reporting their findings. Alongside manual analysis, it is difficult to make critical decisions on patient numbers, site selection, and protocol structure without a complete dataset. TrialKey's AI SaaS automates and optimises trial design. TrialKey automates trial design by analysing 30 years of global trial data and running 100,000 simulations per trial. It applies the law of averages to recommend the best patient numbers, site selection, and protocol structure. If budgets are tight, it predicts how reducing patient numbers will impact success. It also recommends the best trial locations based on healthcare systems, patient demographics, and feasibility, factors that directly influence trial outcomes. Keen to learn how TrialKey can automate your clinical trial processes? Lets chat https://appt.link/minhthu #podcast #ai #biotech #opyl #biotechinvesting #biotechinvestment #aiautomation #clinicaltrials #medtech #aiinhealthcare #drugdiscovery #clinicaltrialresults #clinicaltrialstartup

We’re excited to announce a strategic partnership with Avion, a leading full-service CRO, to bring AI-powered insights to clinical trial design and execution. By combining TrialKey with Avion’s expertise, we’re helping make smarter, data-driven decisions such as improving site selection, recruitment, and trial success rates. Dr Sam Vohra, Founder & CEO of Avion, said: "We are thrilled to partner with Opyl and integrate the TrialKey platform into our operations. This collaboration sets a benchmark for leveraging technology to optimise clinical trial strategies and achieve better outcomes for sponsors, patients, and the wider healthcare ecosystem." Damon Rasheed, Chief Technology Officer of Opyl, added: "This partnership is a testament to the growing demand for TrialKey across the APAC region and beyond. Our continued collaborations with respected CROs, like Avion, demonstrate the industry’s confidence in our platform and its potential to transform clinical trials. Together, we’re driving a shift toward data-driven strategies that deliver faster, more efficient, and higher-quality trial outcomes." This is another step forward as Opyl continues to grow across APAC and beyond. We’re redefining how trials are designed and executed. AI is changing the game, and we’re leading the way. Investor enquires: bernice@trialkey.ai Enquire about TrialKey’s AI SaaS solutions: https://appt.link/minhthu #CRO #partnership #announcement #asx #clinicaltrials #pharma #fullservicecro #medicalresearch #aiinhealthcare #biotech #biotechnews 

Join Opyl and Phenix Health Pty Ltd for an informative virtual webinar exploring how The Compendium and TrialKey support prescribers in navigating medicinal cannabis. Learn how this partnership enhances clinical decision-making and access to critical data. Tailored for healthcare professionals, this session demonstrates how trusted, research-backed data and advanced clinical trial tools empower prescribers to make informed, efficient, and confident decisions. Speakers: Damon Rasheed – CTO and Executive Director, Opyl Gillian Alexis – Founder, Phenix Health Moderated by Bernice Averion, Head of Marketing and Communications, Opyl When: 10am March 11th 2025 Where: https://lnkd.in/gWu3X5Q6 What You’ll Learn: How TrialKey’s AI-validated data integrated within The Compendium supports evidence-based choices. Tackling misinformation, data gaps, and time constraints in medicinal cannabis prescribing. Practical applications to improve prescribing accuracy and patient outcomes. Insights into advancements shaping medicinal cannabis treatment. Why Attend? Gain exclusive access to cutting-edge tools for clinical data analysis and prescribing. Discover practical strategies to improve efficiency and confidence in treatment planning. Hear from industry leaders dedicated to advancing patient care and clinician support. Reserve your spot today! #webinar #biotech #asx #biotechinvestment #phenixhealth #telehealth #cannabanoid #medicine #thecompendium #clinicaltrials #medicalresearch #medicalinnovation

Continuing a successful collaboration: Biointelect Pty Ltd shares how TrialKey’s AI-powered tools are helping them deliver innovative, high-quality clinical trials across Australia and globally. Discover how partnering with TrialKey can enhance your clinical research: trialkey.ai/partnerships #clinicaltrials #clinicalresearch #aiinnovation #biostatistics #trialkeypartnerships #medicalresearch #drugdevelopment #healthcareinnovation

Today, Opyl hosted a virtual webinar titled “The Strategic Advantage of Expert CRO Partnerships", featuring A/Prof Tina Soulis ALITHIA LIFE SCIENCES (CRO) from Alithia Life Sciences, Dr Minh-Thu C. from Opyl, and moderated by Bernice Averion, Head of Marketing and Communications at Opyl. The recording can be found here https://lnkd.in/gKuySUKB The key talking points covered: AI in Clinical Trial Design Protocol Design, Site Selection and Feasibility Assessments Optimising Trial Sites and Enrolment Competitor Benchmarking and Technology Analysis CRO and AI Collaboration Regulatory and Clinical Strategy Expertise Emerging Trends in Clinical Trials Thank you Tina for sharing your expertise, and for our attendees for your time, and patience during the technical difficulties encountered midway. Marketing & Investor enquiries: bernice@trialkey.ai Discuss a FREE TrialKey Preliminary Report: https://appt.link/minhthu Follow Opyl to stay up to date on our next webinar, and other exciting announcements! #cro #pharma #clinicaltrials #feasibility #drugdiscovery #medicalresearch #ai

Opyl is Heading to Europe! Dr Minh-Thu C. will proudly represent team Opyl as part of the Global Victoria supported Australian delegation. During this exciting week, Minh-Thu will engage in high-level meetings and networking events with leading CROs and pharmaceutical companies. She will also attend BIO-Europe Spring 2025, taking place from March 17–19 in Milan, Italy. Face-to-face discussions with global industry leaders help us foster valuable connections, raise brand awareness, and showcase TrialKey, our flagship platform. With advanced predictive analytics, machine learning, and biostatistical validation, TrialKey is revolutionising trial design by delivering precise, data-backed solutions to enhance success and efficiency. BIO-Europe Spring is the premier partnering conference for the life sciences industry, bringing together over 3,700 delegates from 2,000 companies across 59 countries. Milan, a hub of pharmaceutical and biotech innovation, boasts over 250 companies in the sector and is the EU’s largest producer of pharmaceutical products, employing nearly 20% of Italy’s life sciences workforce. This dynamic environment makes it the perfect backdrop for TrialKey to shine. If you are attending BIO-Europe Spring and would like to connect with Minh-Thu, you can schedule a meeting via the BIO Partnering app starting February 3rd. For more information about TrialKey and to enquire about our FREE Preliminary Reports, visit https://appt.link/minhthu.  See you in Milan! #BIOEuropeSpring #opyl #trialkey #biotech #BIO #biopharma #clinicaltrials #medtech #pharma #phaseii #phaseiii #clinicaltrialresults 

Make your proposals stand out! TrialKey’s AI-powered, client-branded preliminary report gives CROs a data-driven edge in proposals, showcasing trial success probabilities, competitor benchmarks, and site recommendations—all designed to increase sponsor confidence. And when the project’s won, our full report dives even deeper, covering endpoint designs, patient criteria, and risk mitigation. Book a demo to discover more: appt.link/minhthu #clinicalresearch #cro #trialdesign #clinicalinsights #healthtech #biostatistics #trialkey

Opyl will host its 4C Quarterly Report presentation via webinar on Thursday, 30 January 2025, at 10:30 AM AEDT. The webinar will provide an opportunity for shareholders, investors, and stakeholders to gain insights into Opyl’s financial performance, recent developments, and strategic initiatives for TrialKey. Attendees will also have the opportunity to participate in a Q&A session with the executive team. Webinar Details: Date: Thursday, 30 January 2025 Time: 10:30 AM AEDT Format: Online Webinar How to Join: Participants can register for the webinar via the following link: https://lnkd.in/gNUNXbUH Speakers: Damon Rasheed, CTO of Opyl Bernice Averion, Head of Marketing & Communications #asx #biotech #cro #pharma #clinicaltrials #webinar #biotechinvestment #smallcap #investingnews